Maureen McEvoy

Articles by Maureen McEvoy

39 Development and Validation of a Questionnaire to Assess Motivation and Satisfaction in Mastectomy Patients With or Without Reconstruction

ByEleni Kohilakis,Evan Rothchild,Maya Rosen,Emma Bentley-Hicks,Alessandra Taboada,Maureen McEvoy

June 1st 2025

63 Intraoperative Radiation and External Beam Radiation After Breast-Conserving Surgery in an Ethnic Minority Population: Patient Reported Outcomes Using BREAST-Q

BySheng Chow,Meredith Shamamian,Susan Laura Jao,Andreina Giron,Jessica Lin,Fardeen Bhimani,Eleni Kohilakis,Caroline Oska,Jana Fox,Sheldon Feldman,Maureen McEvoy

May 14th 2025

64 A Prospective Study to Accurately Define the Nipple-Ward Margins in Patients Undergoing Lumpectomy for Breast Cancer

BySusan Laura Jao,Fardeen Bhimani,Arianna Cavalli,Bryan Harmon,Maureen McEvoy,Ethan Ravetch,Michelle Sheckley,Anjuli Gupta,Sheldon Feldman

May 13th 2025

68 Upper Extremity Disability Assessment Following Breast Cancer Surgery Using QuickDASH in an Ethnic Minority Population

ByArianna Cavalli,Susan Laura Jao,Skylar Harbour,Melissa Rony,Sheldon Feldman,Maureen McEvoy

May 10th 2025

40 Ethnic Disparities in Complication Rates and Outcomes of Nipple-Sparing Mastectomy: A Comprehensive Analysis

ByArianna Cavalli,Fardeen Bhimani,Lesley G. Coe,Liane N. Obaid,Anjuli Gupta,Jessica Pastoriza,Sheldon Feldman,Maureen McEvoy

June 8th 2024

49 The Influence of Race on Complications in Breast Conservation Surgery: A Single Institution Study

ByLiane N. Obaid,Janice S. Zhang,Grace Y. Lee,Fardeen Bhimani,Lesley G. Coe,Arianna Cavalli,Anjuli Gupta,Jessica Pastoriza,Sheldon Feldman,Maureen McEvoy

May 22nd 2024

56 Predictive Factors Correlating With Pathologic Complete Response Rates in Racially Diverse, Minority Populations Receiving Neoadjuvant Therapy for HR+/HER2– Breast Cancer

ByLesley G. Coe,Fardeen Bhimani,Liane N. Obaid,Arianna Cavalli,Anjuli Gupta,Jessica Pastoriza,Sheldon Feldman,Maureen McEvoy

May 14th 2024

Latest Updated Articles

Trending on CancerNetwork

From Accelerated Approval to Reapproval of Belantamab Mafodotin

DREAMM-7 Study Design and the Rationale

EXCALIBER-RRMM: Iberdomide in Relapsed/Refractory Multiple Myeloma

Multimodal Biopsy Combo Shows Low Morbidity in Suspected Prostate Cancer

Alliance A071801 Supports Fractionated SRS After Brain Metastasis Surgery